
Tussastopp - Oral solution
200 mlDelivery to your door
please contact customer support for the exact information
Dies ist ein Arzneimittel. Zu Risiken und Nebenwirkungen fragen Sie Ihren Arzt oder Apotheker. Wir stehen Ihnen gerne unter (+43 (1) 343 43 53) oder per E-Mail (gurkerl@beavit.at) zur Verfügung.
- Description
- Composition
- Similar products
- More from this brand
- Recipes
The active ingredient in Tussastopp, dextromethorphan, inhibits the coughing stimulus by inhibiting the cough reflex in the brainstem.
Application
WHAT IS Tussastopp Oral Solution AND WHAT IS IT USED FOR?
The active ingredient in Tussastopp, dextromethorphan, inhibits the coughing stimulus by inhibiting the cough reflex in the brainstem.
Application:
For the treatment of irritable coughs and cramp-like coughs with various causes, e.g. in colds, flu-like infections as well as smoker's cough.
How is it applied?
What is Tussastopp and what is it used for?
The active ingredient in Tussastopp, dextromethorphan, inhibits the coughing stimulus by inhibiting the cough reflex in the brainstem.
Application:
For the treatment of irritable coughs and cramp-like coughs with various causes, e.g. in the case of colds, flu-like infections as well as smokers' coughs.
In self-treatment with Tussastopp, the application should not last longer than 3 -5 days. If the cough has not disappeared or
not decreased significantly after a treatment period of 3 - 5 days, or if it has even worsened or complications occur, consult your doctor.
What should you pay attention to before taking it?
What should you be aware of before taking tussastopp?
Tussastopp must not be taken,
- If you are allergic to dextromethorphan or any of the other ingredients of this medicine listed in section 6 .
- If you suffer from one or more of the following diseases:
Bronchial asthma, chronic obstructive respiratory disease (caused by narrowing of the airways), pneumonia, respiratory disorders (respiratory insufficiency, respiratory depression) .
- During breast-feeding (see "Pregnancy and breast-feeding") .
Please talk to your doctor and pharmacist before taking Tussastopp,
- if your liver function is impaired .
- When certain mood-lifting medicines (so-called MAO inhibitors) are used at the same time (see "Taking tussastopp together with other medicines") .
In cases of productive cough with considerable mucus production (sputum), cough-inhibiting treatment with Tussastopp should only be carried out with particular caution after a strict risk-benefit assessment. If you experience any of these symptoms, you should consult a doctor.
Chronic cough can be an early symptom of bronchial asthma, so Tussastopp must not be used to dampen down this cough - especially in children.
Dextromethorphan has a low dependence potential. With prolonged use of dextromethorphan, habituation, mental and physical dependence may develop. Cases of abuse of dextromethorphan have been reported. Caution is especially advised in adolescents and young adults, and in patients with a history of drug abuse or use of psychoactive substances. In patients who are prone to drug abuse or drug dependence, treatment with Tussastopp is therefore only advisable for a short time and under the strictest medical supervision.
If misused, overdose symptoms may occur (see "If you have taken more tussastopp than you should").
If the cough has not disappeared after a treatment period of 3 - 5 days or
have not decreased significantly or have even worsened or complications occur, contact your doctor.
If you become pregnant during treatment with Tussastopp, please contact your doctor.
First signs of side effects should be reported to the doctor immediately.
Taking Tussastopp with other medicines.
Inform your doctor or pharmacist if you are taking/using, have recently taken/used or intend to take/use any other medicines.
If other medicinal products with a depressant effect on the central nervous system, such as barbiturates, hydroxyzine and benzodiazepines, are taken at the same time, their effects may be enhanced.
Pre-treatment of patients with or concomitant use of certain mood-altering with simultaneous use of certain mood-boosting medicines (antidepressants of the MAO inhibitor type or SSRIs [fluoxetine, paroxetine], a serious, sometimes life-threatening clinical picture (so-called serotonin syndrome) may occur with the following symptoms: high fever, muscular rigidity, mental changes such as states of agitation and confusion, as well as changes in respiratory and circulatory functions.
In the case of simultaneous use of medicines that inhibit a certain enzyme system in the liver and thus the degradation of dextromethorphan - in particular amiodarone, quinidine, flecainide, propafenone (each for cardiac arrhythmias), fluoxetine, paroxetine (both for depression)fluoxetine, paroxetine (both for depression), sertraline, bupropion (both for depression), haldoperidol, perphenazine, thioridazine (each for certain mental illnesses), methadone (strong painkiller), cinacalcet (for parathyroid hyperfunction), cimetidine, citraline, citraline, cimetidine, cimetidine, cimetidine, cimetidine, cimetidine, cimetidine, cimetidine, cimetidine, cimetidine and cimetidine.(to treat hyperparathyroidism), cimetidine (to treat excessive stomach acid), terbinafine (to treat fungal infections) and ritonavir (to treat HIV infections) - the concentration of dextromethorphan may increase.
In this context, complaints of overdose have been observed (see "If you have taken more tussastopp than you should").
The simultaneous use of tussastopp and sedatives such as benzodiazepines or related medicines increases the risk of drowsiness, breathing difficulties (respiratory depression), coma and can be life-threatening. Therefore, concomitant use should only be considered if other treatment options are not an option.
If your doctor nevertheless prescribes you tussastopp at the same time as sedatives, the dosage and duration of the simultaneous treatment must be limited by your doctor.
Please inform your doctor of any sedatives you are taking and follow your doctor's dosage recommendations exactly. It can be helpful to tell friends or relatives to look out for the signs and symptoms described above in you. If you experience such symptoms, consult your doctor.
When Tussastopp oral solution is used in combination with secretolytics (expectorants), a dangerous build-up of secretions can occur due to the impaired cough reflex.
Pregnancy, lactation and reproductive capacity.
If you are pregnant or breast-feeding, or if you suspect you may be pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before using this medicine.
Pregnancy
Studies and observations in humans have so far shown no evidence of a fruit-damaging effect of dextromethorphan.
High doses of dextromethorphan can possibly cause respiratory depression in the newborn - even if they are only administered for a short time.
Therefore, Tussastopp should only be used during pregnancy after a strict risk/benefit assessment by the doctor and only in exceptional cases.
Breastfeeding time
Studies on the transfer of dextromethorphan into breast milk are not available. As a respiratory depressant effect on the baby cannot be ruled out, Tussastopp must not be taken during breast-feeding.
Driving ability and ability to operate machinery.
! Caution: This medicinal product may impair the ability to react and drive.
Dextromethorphan may occasionally cause drowsiness even when used as directed. This may alter the ability to react to such an extent that the ability to actively participate in road traffic or to operate machinery may be impaired. This is especially true if alcohol is consumed at the same time or in combination with medicines, which in turn can impair the ability to react.
Tussastopp contains maltitol solution and propylene glycol.
Please only take Tussastopp after consulting your doctor if you are known to suffer from a sugar intolerance.
This medicinal product contains propylene glycol, which may cause central nervous system disorders similar to those after alcohol ingestion.
How should the medicine be taken?
How to take Tussastopp?
Always take Tussastopp exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
A measuring spoon with markings at 1.25 ml, 2.5 ml and 5 ml is provided for accurate dosing.
Dosing:
Adults and adolescents 12 years and over:
10 - 15 mg every 4 to 6 hours (1 -1½ scoops to 5ml).
The maximum daily dose is 60 mg.
The medicine should not be taken more than 4 times a day.
Children up to 12 years of age:
The medicine is not suitable for these patients due to the amount of active substance contained in one dose.
Mode of administration
The enclosed measuring spoon is to be used for taking the solution by filling it with solution up to the respective mark.
After use, rinse the measuring spoon.
For self-treatment with Tussastopp, the intake should not last longer than 3 - 5 days. Even if prescribed by a doctor, treatment with Tussastopp should not last longer than 2 - 3 weeks.
Please talk to your doctor if you have the impression that the effect of Tussastopp is too strong or too weak. You must not under any circumstances increase the dosage recommended in the package leaflet on your own initiative.
If you have taken a larger amount of Tussastopp than you should
.Taking very high doses, 300 mg or more of dextromethorphan may cause agitation, dizziness, increased muscle tension, psychotic states such as.If you take very high doses, 300 mg or more of dextromethorphan, you may experience agitation, dizziness, increased muscle tension, psychotic states such as delusions, impaired consciousness, respiratory depression, drowsiness, drop in blood pressure, increased heart rate, eye tremor (nystagmus), pupil dilation, tremor, increased reflexes, impaired motor function and confusion.
If | You | |
one | to | has been taken, contact a |
Doctor/emergency doctor. | This | |
Decide on measures. Have a pack of the medicine ready for the doctor to check | ||
can inform the ingested agent. |
- Instructions for the physician:
If necessary, initiate intensive medical monitoring with symptom-related therapy. Naloxone can be used as an antagonist (dosage information can be found in the corresponding specialist information).
You must not make up the intake by doubling the dose at the next intake. Instead, just take the usual following dose at the usual time.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
What are the possible side effects?
How to store Tussastopp?
Keep this medicine out of the reach of children.
Store in the original packaging.
You must not use this medicine after the expiry date which is stated on the outer carton after "Use by:". The expiry date refers to the last day of the month indicated.
After opening, the solution is stable for 6 months.
Do not dispose of medicines in waste water or household waste. Ask your pharmacist how to dispose of the medicine when you stop using it. In doing so, they contribute to the protection of the environment.
Special instructions for storage
HOW TO STORE Tussastopp Oral Solution?
Store the medicine out of the reach of children.
Store in the original packaging.
You must not use the medicinal product after the expiry date which is stated on the outer carton after ,,Use by:". The expiry date refers to the last day of the month.
After opening, the solution is stable for 6 months.
The medicinal product must not be disposed of in waste water or household waste. Ask your pharmacist how to dispose of the medicine when you no longer need it. This measure helps to protect the environment.
Special notes on the content
Contents of the pack and further information
What Tussastopp contains
- The active ingredient is dextromethorphan.
- The other ingredients are:
Like Tussastopp Looks like and contents of the pack.
Clear solution with strawberry flavour.
Tussastopp is available in packs of 125, 200 ml.
Information leaflet
Download the information leafletWirkstoff: DEXTROMETHORPHAN HYDROBROMID
EAN: 09088883521363, 9088883521363
PZN: 3521366